Company InVivo Therapeutics Holdings Corp.
Equities
NVIV
US46186M6057
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.38 USD | +2.70% | -5.00% | -47.95% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director/Board Member | 80 | 10-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,105,446 | 3,104,797 ( 99.98 %) | 0 | 99.98 % |
Company contact information
Invivo Therapeutics Holdings Corp.
Building 1400 West One Kendall Square
02139, Cambridge
+617 863 5500
http://www.invivotherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
-47.95% | 1.18M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+1.56% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- NVIV Stock
- Company InVivo Therapeutics Holdings Corp.